v1
Omacetaxine Mepesuccinate for Patients with Higher-Risk MDS and CMML after Failure of Hypomethylating Agents: A Phase II Trial
- NobleID
- NI8P24W51R58S84
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/EB680B96
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →